Narix Pharmaceuticals Private Limited

Catapres (Clonidine) Tablet Central Alpha-2 Agonist for Hypertension & ADHD Narix Pharmaceuticals Narix Pharmaceuticals manufactures Clonidine Tablets, a centrally acting alpha-2 adrenergic agonist with multiple therapeutic applications including hypertension, ADHD, opioid withdrawal management, and menopausal hot flashes. Key Therapeutic Uses: � Hypertension � especially resistant cases � ADHD � non-stimulant alternative � Opioid and alcohol withdrawal management � Menopausal hot flashes � Perioperative hemodynamic control Available Strengths: 0.1 mg 0.2 mg 0.3 mg Product Highlights: � Multiple therapeutic applications � WHO-GMP, DCGI approved � Alu-Alu blister packs, bulk export � PCD pharma franchise available Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #ClonidineTablet #CatapresGeneric #Alpha2Agonist #AntihypertensiveTablet #ADHDMedicine #OpioidWithdrawal #ClonidineManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Livalo (Pitavastatin) Tablet Next-Generation Statin with Minimal Drug Interactions Narix Pharmaceuticals Narix Pharmaceuticals manufactures Pitavastatin Tablets, a synthetic high-potency statin with minimal CYP450 metabolism, ideal for patients on HIV antiretrovirals, immunosuppressants, and other interacting medications. Key Therapeutic Uses: � Primary hypercholesterolemia and mixed dyslipidemia � Polypharmacy patients (HIV, transplant, antifungal therapy) � Superior HDL-raising effect vs other statins � Patients on cyclosporine or antiretrovirals Available Strengths: 1 mg 2 mg 4 mg Product Highlights: � Minimal drug interactions � safe for complex patients � WHO-GMP certified, DCGI approved � Alu-Alu blister packs, bulk export ready � PCD franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #PitavastatinTablet #LiveloGeneric #NextGenStatin #LowInteractionStatin #CholesterolMedicine #PitavastatinManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #HIVPatientStatin

Inderal (Propranolol) Tablet Non-Selective Beta-Blocker for Hypertension & Arrhythmia Narix Pharmaceuticals Narix Pharmaceuticals manufactures Propranolol Tablets, a non-selective beta-adrenergic blocker used for hypertension, angina, arrhythmias, migraine prophylaxis, essential tremor, and thyrotoxicosis management. Key Therapeutic Uses: � Hypertension and angina pectoris � Cardiac arrhythmias � AF rate control, SVT � Migraine prophylaxis and essential tremor � Thyrotoxicosis � pre-operative management � Portal hypertension in liver cirrhosis Available Strengths: 10 mg 20 mg 40 mg 80 mg 160 mg LA Product Highlights: � Immediate release & long-acting formulations � WHO-GMP, DCGI approved � Alu-Alu blister packs, bulk export ready � PCD pharma franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #PropranololTablet #InderalGeneric #BetaBlocker #AntihypertensiveTablet #AntiarrhythmicMedicine #MigrainePrevention #PropranololManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Pletal (Cilostazol) Tablet PDE3 Inhibitor Antiplatelet for Peripheral Artery Disease Narix Pharmaceuticals Narix Pharmaceuticals manufactures Cilostazol Tablets, a selective PDE3 inhibitor with both vasodilatory and antiplatelet properties � proven superior to pentoxifylline for improving walking distance in peripheral artery disease and intermittent claudication. Key Therapeutic Uses: � Peripheral artery disease � intermittent claudication (first-line) � Post-stent antiplatelet therapy � coronary and peripheral � Stroke secondary prevention � Asian guidelines � Prevention of restenosis after coronary angioplasty Available Strengths: 50 mg 100 mg Product Highlights: � Superior to pentoxifylline for claudication � CASTLE trial � WHO-GMP, DCGI approved � Antiplatelet + vasodilator dual mechanism � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CilostazolTablet #PletalGeneric #CiloGeneric #PDE3Inhibitor #PeripheralArteryDisease #ClaudicationTablet #CilostazolManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Multaq (Dronedarone) Tablet Non-Iodinated Antiarrhythmic for Atrial Fibrillation Narix Pharmaceuticals Narix Pharmaceuticals manufactures Dronedarone Tablets, a multichannel-blocking antiarrhythmic structurally related to amiodarone but without iodine moiety, significantly reducing thyroid and pulmonary toxicity risk. Key Therapeutic Uses: � Paroxysmal or persistent AF/flutter � rhythm maintenance � Reduction of cardiovascular hospitalizations in AF � Rate control in AF as beta-blocker alternative Available Strengths: 400 mg Product Highlights: � Non-iodinated � lower toxicity vs amiodarone � WHO-GMP, DCGI approved � Bulk export to Africa, MENA, ASEAN � PCD pharma franchise available Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DronedaroneTablet #MultaqGeneric #AntiarrhythmicTablet #AtrialFibrillationMedicine #AFibTablet #DronedaroneManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #RhythmControl

Vastarel (Trimetazidine) Tablet Metabolic Anti-Ischemic for Stable Angina Narix Pharmaceuticals Narix Pharmaceuticals manufactures Trimetazidine Modified-Release Tablets, a metabolic anti-ischemic agent that inhibits 3-ketoacyl-CoA thiolase, shifting cardiac energy metabolism from fatty acid to glucose oxidation for improved myocardial efficiency. Key Therapeutic Uses: � Stable angina pectoris � add-on or monotherapy � Tinnitus and vertigo of ischemic vascular origin � Ischemic heart disease � cardiac metabolic support � Post-MI cardiac rehabilitation Available Strengths: 20 mg 35 mg MR Product Highlights: � No hemodynamic effect � safe in all BP ranges � WHO-GMP, DCGI approved manufacturing � MR formulation � twice-daily dosing � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TrimetazidineTablet #VastarelGeneric #AntiAnginalTablet #MetabolicAntiIschemic #StableAngina #TrimetazidineManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Effient (Prasugrel) Tablet Third-Generation Antiplatelet for ACS & PCI Narix Pharmaceuticals Narix Pharmaceuticals manufactures Prasugrel Tablets, a potent third-generation P2Y12 ADP receptor antagonist used in ACS patients undergoing PCI, with faster onset and greater platelet inhibition than clopidogrel. Key Therapeutic Uses: � ACS (STEMI, NSTEMI, unstable angina) managed with PCI � Reduction of thrombotic cardiovascular events post-stent � Dual antiplatelet therapy with Aspirin Available Strengths: 5 mg 10 mg Product Highlights: � WHO-GMP, DCGI approved manufacturing � Alu-Alu blister, 24-month shelf life � Bulk export with COPP, FSC documentation � PCD pharma franchise available Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #PrasugrelTablet #EffientGeneric #AntiplateletTablet #ACSMedicine #PCIMedicine #PrasugrelManufacturer #ThienopyridineAntiplatelet #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Twynsta (Telmisartan + Amlodipine) Tablet India's Top ARB + CCB FDC Antihypertensive Narix Pharmaceuticals Narix Pharmaceuticals manufactures Telmisartan + Amlodipine FDC Tablets, one of the most prescribed antihypertensive combinations in India. Provides 24-hour BP control with complementary ARB and CCB mechanisms. Key Therapeutic Uses: � Hypertension requiring combination therapy � High CV risk hypertensive patients � Hypertension with metabolic syndrome � Better tolerated than ACE inhibitor combinations Available Strengths: Telmisartan 40 mg + Amlodipine 5/10 mg 80 mg + 5/10 mg Product Highlights: � India's top-selling antihypertensive FDC � 24-hour single-dose coverage � WHO-GMP, DCGI approved manufacturing � PCD pharma franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TelmisartanAmlodipineTablet #TwynstaGeneric #TelmaAMGeneric #ARBCCBCombo #FDCAntihypertensive #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #TopAntihypertensiveIndia

Questran (Cholestyramine) Tablet Bile Acid Sequestrant for Cholesterol & Bile Acid Diarrhea Narix Pharmaceuticals Narix Pharmaceuticals manufactures Cholestyramine Tablets/Powder, a bile acid sequestrant resin that binds bile acids in the intestine preventing reabsorption � used for hypercholesterolemia, bile acid malabsorption diarrhea, and pruritus in cholestasis. Key Therapeutic Uses: � Primary hypercholesterolemia � LDL reduction � Bile acid malabsorption diarrhea (post-ileal resection, post-cholecystectomy) � Pruritus in biliary cirrhosis and cholestasis � Digitalis toxicity � bind digitalis in overdose � Type 2 diabetes � modest glycemic benefit Available Strengths: 4 g sachets Cholestyramine 500 mg tablets Product Highlights: � Non-systemically absorbed � safe profile � WHO-GMP, DCGI approved � Effective for bile acid diarrhea � unique indication � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #CholestyramineMedicine #QuestranGeneric #BileAcidSequestrant #CholesterolMedicine #BileAcidDiarrhea #CholestyramineMfg #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine #Pruritus

Aldactone (Spironolactone) Tablet Potassium-Sparing Diuretic Narix Pharmaceuticals Narix Pharmaceuticals manufactures Spironolactone Tablets, a potassium-sparing aldosterone antagonist used in heart failure, hypertension, primary hyperaldosteronism, edema, and hormonal acne (off-label). Spironolactone blocks aldosterone receptors in the distal tubule, reducing sodium retention while preserving potassium. Key Therapeutic Uses: � Heart failure (reduced ejection fraction) � reduces mortality � Primary hyperaldosteronism (Conn's syndrome) � Edema due to nephrotic syndrome, liver cirrhosis � Resistant hypertension as add-on therapy � Hormonal acne and PCOS management (off-label) Available Strengths: 25 mg 50 mg 100 mg Product Highlights: � WHO-GMP certified, DCGI approved � Alu-Alu blister packs, 24-month shelf life � Bulk export with COPP & FSC documentation � PCD pharma franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Approved Schedule M Compliant #SpironolactoneTablet #AldactoneGeneric #PotassiumSparingDiuretic #HeartFailureMedicine #HypertensionTablet #SpironolactoneManufacturer #CardiacMedicine #WHOGMPCertified #PCDPharma #NarixPharmaceuticals #PharmaceuticalExporter #GenericMedicine

Dexilant (Dexlansoprazole) Capsule Dual Delayed-Release PPI for 24-Hour Acid Control Narix Pharmaceuticals Narix Pharmaceuticals manufactures Dexlansoprazole Capsules, the R-enantiomer of lansoprazole with a unique dual delayed-release (DDR) formulation providing two separate pH-dependent release phases � offering 24-hour acid control superior to single-release PPIs. Key Therapeutic Uses: � GERD and erosive esophagitis � healing and maintenance � Nighttime acid breakthrough � dual release controls nocturnal acid � PPI-refractory GERD � step-up therapy � Maintenance of erosive esophagitis remission Available Strengths: 30 mg 60 mg DDR Product Highlights: � Dual delayed-release � two absorption peaks, 24-hour control � Superior nighttime acid control � WHO-GMP, DCGI approved � Can be taken without regard to meals � PCD pharma franchise & bulk export Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #DexlansoprazoleCapsule #DexilantGeneric #DualDelayedReleasePPI #24HourAcidControl #GERDMedicine #DexlansoprazoleManufacturer #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Corlanor (Ivabradine) Tablet Selective If Channel Blocker for Heart Failure & Angina Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ivabradine Tablets, the first selective funny current (If) channel inhibitor that reduces heart rate without affecting contractility or blood pressure. SHIFT trial proven to reduce HF hospitalizations. Key Therapeutic Uses: � Chronic heart failure with reduced EF (HFrEF) � reduces hospitalizations � Stable angina in patients intolerant to beta-blockers � Inappropriate sinus tachycardia � Add-on when beta-blockers alone insufficient Available Strengths: 5 mg 7.5 mg Product Highlights: � Unique MOA � pure heart rate reduction without hemodynamic compromise � WHO-GMP, DCGI approved � Alu-Alu blister packs, bulk export � PCD pharma franchise & third-party manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #IvabradinTablet #CorlanorGeneric #HCNChannelBlocker #HeartRateReduction #HeartFailureMedicine #AnginaTablet #IvabradinManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine

Zetia (Ezetimibe) Tablet Selective Cholesterol Absorption Inhibitor Narix Pharmaceuticals Narix Pharmaceuticals manufactures Ezetimibe Tablets, a selective cholesterol absorption inhibitor that blocks NPC1L1 transporter in the small intestine, reducing LDL cholesterol by 18-25% as monotherapy and up to 60% combined with statins. Key Therapeutic Uses: � Primary hypercholesterolemia � monotherapy or with statins � Homozygous familial hypercholesterolemia (add-on) � Sitosterolemia (phytosterolemia) � Combination with Simvastatin / Rosuvastatin / Atorvastatin FDC Available Strengths: 10 mg Product Highlights: � WHO-GMP, DCGI approved � Widely exported as standalone or FDC formulation � Ezetimibe + Simvastatin Ezetimibe + Rosuvastatin FDCs available � PCD franchise & bulk manufacturing Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #EzetimibeTablet #ZetiaGeneric #CholesterolAbsorptionInhibitor #LipidLowering #CholesterolTablet #EzetimibeManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #PharmaceuticalExporter #GenericMedicine #FDCTablet

Demadex (Torsemide) Tablet Superior Loop Diuretic for Heart Failure & Edema Narix Pharmaceuticals Narix Pharmaceuticals manufactures Torsemide Tablets, a loop diuretic with superior oral bioavailability (80-100%) vs furosemide (~50%), providing more consistent and predictable diuresis in heart failure. Key Therapeutic Uses: � Edema in congestive heart failure � preferred diuretic � CKD-associated edema � Hypertension � resistant cases � Ascites in liver cirrhosis Available Strengths: 5 mg 10 mg 20 mg 100 mg Product Highlights: � Higher bioavailability than furosemide � Less ototoxicity at equivalent doses � WHO-GMP, DCGI approved � Bulk export & PCD pharma franchise Certifications: WHO-GMP ISO 9001:2015 DCGI Schedule M #TorsemideTablet #DemadexGeneric #LoopDiuretic #HeartFailureDiuretic #EdemaTablet #TorsemideManufacturer #CardiacMedicine #PCDPharma #WHOGMPCertified #NarixPharmaceuticals #GenericMedicine